)
Pacira BioSciences (PCRX) investor relations material
Pacira BioSciences Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
A proxy contest is underway for the 2026 annual meeting, with a dissident stockholder, DOMA Perpetual Capital Management LLC, proposing an alternative slate of directors.
The board urges shareholders to support its nominees and proposals to continue executing the 5x30 long-term value creation strategy.
Forward-looking statements highlight growth strategies, product development, and market expansion, with caution regarding risks and uncertainties.
Voting matters and shareholder proposals
Shareholders will vote on the election of three Class III directors: Christopher Christie, Samit Hirawat, and Thomas Wiggans, recommended by the board.
The board recommends voting FOR the appointment of KPMG as independent auditor, executive compensation, the amended stock plan, and the amended employee stock purchase plan.
Shareholders are urged to disregard proxy materials from DOMA and withhold votes for DOMA's nominees.
Board of directors and corporate governance
The board and executive leadership emphasize their commitment to acting in the best interests of all stockholders and maintaining company momentum.
Information on director nominees and their interests is available in the proxy statement and related SEC filings.
- Proxy contest aims to overhaul board, oppose pay plans, and push for strategic alternatives.PCRX
Proxy filing12 May 2026 - Board recommends electing three experienced nominees to drive growth and mitigate governance risks.PCRX
Proxy filing12 May 2026 - Q1 2026 revenue hit $177.4M, strong product growth, $50M in buybacks, guidance reaffirmed.PCRX
Q1 20269 May 2026 - Shareholders are urged to back the board’s nominees amid strong growth and strategic execution.PCRX
Proxy filing5 May 2026 - Board urges support for its nominees, equity plan amendments, and KPMG ratification amid record growth.PCRX
Proxy filing28 Apr 2026 - Board urges support for its nominees, citing strong growth, governance, and strategic execution.PCRX
Proxy filing28 Apr 2026 - Board urges support for its nominees, equity plan amendments, and continued growth strategy.PCRX
Proxy filing17 Apr 2026 - EXPAREL growth, new partnerships, and pipeline milestones set the stage for double-digit gains.PCRX
25th Annual Needham Virtual Healthcare Conference15 Apr 2026 - Progress on 5x30 strategy, board nominations, and $150M stock repurchase highlighted.PCRX
Proxy Filing11 Mar 2026
Next Pacira BioSciences earnings date
Next Pacira BioSciences earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Explore our global coverage
)
)